![Andrew Guggenhime](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Guggenhime
Direttore Finanziario/CFO presso
VAXCYTE, INC.
Patrimonio netto: 9 M $ in data 31/05/2026
Profilo
Andrew L.
Guggenhime is Chairman at Caribou Biosciences, Inc. since 2021.
Mr. Guggenhime is President & Chief Financial Officer at Vaxcyte, Inc. since 2023.
Former roles include Director at CardioDx, Inc. from 2014 to 2016, Independent Director at Metacrine, Inc. from 2018 to 2023, Assistant VP-Real Estate Capital Markets Group at Wells Fargo & Co., Chief Financial Officer & Senior Vice President at Neoforma, Inc. from 2000 to 2006, Chief Financial Officer at Calistoga Pharmaceuticals, Inc. from 2010 to 2011, Chief Financial Officer & Senior Vice President at Abbott Biotherapeutics Corp.
from 2008 to 2010, Chief Financial Officer & Senior Vice President at PDL BioPharma, Inc. from 2006 to 2008, Chief Financial Officer at Dermira, Inc. from 2018 to 2020, and Vice President at Merrill Lynch & Co., Inc. from 1996 to 2000.
Education includes undergraduate studies at Middlebury College and an MBA from Kellogg School of Management.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
VAXCYTE, INC. 0,12% | 18/06/2026 | 166.245 ( 0,12% ) | 9 M $ | 31/05/2026 |
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Posizioni attive di Andrew Guggenhime
| Società | Posizione | Inizio |
|---|---|---|
| VAXCYTE, INC. | Direttore Finanziario/CFO | 01/05/2020 |
| CARIBOU BIOSCIENCES, INC. | Presidente | 01/07/2021 |
Precedenti posizioni note di Andrew Guggenhime
| Società | Posizione | Fine |
|---|---|---|
| METACRINE, INC. | Direttore/Membro del Consiglio | 23/03/2023 |
| DERMIRA, INC. | Direttore Finanziario/CFO | 01/05/2020 |
| CARDIODX INC | Direttore Finanziario/CFO | 28/04/2014 |
Calistoga Pharmaceuticals, Inc.
 Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Direttore Finanziario/CFO | 01/04/2011 |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Direttore Finanziario/CFO | 01/06/2010 |
Formazione di Andrew Guggenhime
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
66
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Wells Fargo & Co.
 Wells Fargo & Co. Major BanksFinance Operates as a bank holding company whose subsidiaries provides consumer, commercial, corporate, investment banking and wealth management services | Finance |
Neoforma, Inc.
 Neoforma, Inc. Medical DistributorsDistribution Services Provides e-commerce services to healthcare industry | Distribution Services |
CardioDx, Inc.
 CardioDx, Inc. Medical/Nursing ServicesHealth Services Operates as a cardiovascular genomic diagnostics company | Health Services |
Calistoga Pharmaceuticals, Inc.
Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Health Technology |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
Middlebury College
 Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
Merrill Lynch & Co., Inc.
 Merrill Lynch & Co., Inc. Investment ManagersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Metacrine, Inc.
 Metacrine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in discovery and development of therapies for patients with liver and gastrointestinal diseases | Health Technology |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
